Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial
Article 2011 en
Authors
GE
Gilles Edan
GC
Gıancarlo Comı
EP
Emmanuelle Le Page
Abstract
1 min read
Although there were limitations in this investigator-academic-driven study, the data do suggest that mitoxantrone induction therapy prior to INF beta-1b may have a role in aggressive disease.
Hans Hartung, Lawrence Steinman, Douglas S. Goodin, Giancarlo Comi, Stuart D. Cook, Massimo Filippi, Paul O’Connor, Douglas Jeffery, Ludwig Kappos, Robert C. Axtell, Volker Knappertz, Timon Bogumil, Susanne Schwenke, Ed Croze, Rupert Sandbrink, Christopher Pohl
P. D. Molyneux, Ludwig Kappos, Chris H. Polman, Carlo Pozzilli, Frederik Barkhof, Massimo Filippi, Tarek Yousry, David W. Hahn, Klaus Wagner, Mahdiyeh Khabbaz Koche Ghazi, K. Beckmann, Frank Dahlke, Nicholas Losseff, Gareth J. Barker, Alan J. Thompson, D. H. Miller
Douglas S. Goodin, Hans-Peter Hartung, Paul O’Connor, Massimo Filippi, Barry G.W. Arnason, Giancarlo Comi, Stuart D. Cook, Douglas Jeffery, Ludwig Kappos, Timon Bogumil, Volker Knappertz, Rupert Sandbrink, K. Beckmann, Rick White, John Petkau, Christoph Pohl
Hans-Peter Hartung, Ludwig Kappos, Douglas S. Goodin, Paul O’Connor, Massimo Filippi, Barry G.W. Arnason, Giancarlo Comi, Stuart D. Cook, Douglas Jeffery, John Petkau, Richard White, Timon Bogumil, K. Beckmann, Brigitte Stemper, Gustavo Cruz, Rupert Sandbrink, Christoph Pohl
Discussion(0)
No comments yet. Be the first to comment.